The presence of the ETV6-NTRK3 chimeric oncoprotein has demonstrated oncogenicity in various tumor types, including mammary analog secretory carcinoma, secretory breast carcinoma, and papillary thyroid carcinoma [27,28,29]. This evidence concerns the gene NTRK3 and thyroid gland papillary carcinoma.